Unpublished works on any field (clinical or experimental) in relation to the subjects of the journal. The papers should be structured in: Introduction, Material and method, Results, Discussion and Bibliography. They will have a maximum length of 2000 words (double spaced, Arial 12 letter) and up to 6 tables and 6 figures (with their corresponding feet) will be accepted. They must not exceed 20-30 bibliographic citations. The original works will include a structured summary of 250 words maximum. For the preparation of controlled clinical trials, the CONSORT regulations should be followed. Available at: http://www.consort-statement.org/

The works of revision or update will be proposed by the Writing Committee of the Magazine. They will have a maximum extension of 30 Din-A4 (double spaced, Arial 12 letter) and up to 6 tables and 6 figures will be accepted. They must not exceed 40-50 bibliographic citations. The review papers will include a summary of 150 words.

Exposition of experiences or clinical studies, new techniques, therapeutic trials or clinical cases of exceptional interest. They should be structured in: Introduction, Clinical case, Results, Discussion and Bibliography. Clinical notes will have a maximum extension of 1000 words (double spaced, Arial 12 letter), and less than 15 bibliographic citations.

They will comment on previous works presented in the Journal or provide information on a topic of interest. They must not exceed 3 Din-A4 (double spaced, Arial font 12). Only in exceptional cases can be accompanied by a figure or table and up to 5 citations.

When describing experiments that have been carried out on humans, it must be indicated whether the procedures followed are in accordance with the ethical standards of the responsible human experimentation committee (institutional or regional) and in accordance with the World Medical Association and the Declaration of Helsinki available at: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

 When describing animal experiments, it should be indicated if the guidelines of an international research institution or council or a national law regulating the care and use of laboratory animals have been followed.

The authors are responsible for following the protocols established by their respective health centers in order to access the data of the clinical histories in order to be able to carry out this type of publication with the purpose of research for the community, so they must declare compliance of this requirement. The author has the obligation to guarantee that the requirement of having informed all the patients included in the study and that he/she is in possession of the document signed by them having received sufficient information and having obtained their informed written consent to participate, has been fulfilled. The authors should mention in the section on methods that the procedures used in patients and controls have been carried out after obtaining an informed consent.

The author is also responsible for guaranteeing the right to privacy of patients by protecting their identity both in the writing of their article and in the images. Do not use names, initials or hospital medical record numbers (or any other type of data irrelevant to the research that could identify the patient) or in the text or photographs, unless such information is essential for scientific purposes , in which case you can collect it in the article whenever the patient, or his or her parent or guardian, gives written informed consent for its publication. The authors are responsible for obtaining written consent, authorizing its publication, reproduction and dissemination on paper and Internet freely available on the Internet.

The authors must declare the origin of any financial aid received.

The list of authors should include only those people who have contributed intellectually to the development of the work. To appear as an author, the following requirements must be met:

• To have participated in the conception and design, the acquisition of the data, the analysis and interpretation of the work data that has resulted in the article in question.

• To have participated in the writing of the text and in the possible revisions of it.

• Have approved the version that will finally be published

The title page should include information on the source of funding, if any, institutional affiliations and conflict of interest, in connection with the submitted article. Similarly, you must have permission to publish by the institution that has funded the research.

The journal does not accept previously published material. The authors are responsible for obtaining the appropriate permissions to partially reproduce material (text, tables or figures) of other publications. These permits must be requested both from the author and from the publisher who has published said material.

The journal does not accept previously published material and will not consider for publication manuscripts that are sent simultaneously to other journals, nor redundant or duplicate publications, that is, articles that substantially overlap another already published, printed or electronic media. Authors must inform in the cover letter about previous postings or publications of the same work, in whole or in part, that may be considered redundant or duplicate publication.

These restrictions would not be applicable to the published abstracts of communications, papers or conferences presented at national or international scientific meetings, unless they have a conflict of interest or are in the period of approval by said congress or association.

The judgments and opinions expressed in the articles and communications published in the journal are those of the authors, and not necessarily those of the Editorial Committee. Both the Editorial Board and the publishing company decline any responsibility for such material. Neither the Editorial Committee nor the publishing company guarantee or support any product that is advertised.